Related Experiment Video
Updated: Aug 15, 2026

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
Worldwide Innovative Network Consortium: Building a Common Global Cancer Database
Farhood Farahnak1, Wafik S El-Deiry2,3, Yves A Lussier4
1McGill University Centre for Translational Research in Cancer and Segal Cancer Centre, Jewish General Hospital, Montreal, QC, Canada.
Abstract:
This review shares the ongoing work of the global Worldwide Innovative Network (WIN) Consortium for Precision Medicine to synthesize emerging cancer treatment data and to define the requirements for a common global cancer database that can truly support precision oncology. We performed a narrative review of emerging cancer treatment data, molecular profiling technologies, and existing clinicogenomic databases, focusing on how tumors are characterized, how subgroups are defined, and how demographic, lifestyle, and environmental factors are captured. The growth in molecular profiling technologies and the development of new targeted therapies are transforming cancer care. Tumors, regardless of tissue origin, are increasingly defined as composites of multiple, often rare, subgroups, each with distinct biology and likely response to specific therapies, based on multidimensional profiling of the tumor and its microenvironment. The solution lies in building vast databases that capture racial and ethnic diversity, reflected in genomic data, as well as diet and lifestyle factors that may have epigenetic impact on gene expression and post-translational modifications. A truly inclusive and informative data set must reflect global diversity, and there are multiple examples of demography-dependent differences in genomic signals. With members caring for and studying patients with cancer across five continents, WIN is actively exploring pathways to create a global cancer database, rich in clinical and molecular detail, granular enough for precise analysis, and large enough to power artificial intelligence-driven insights, provided appropriate data quality, validation, and governance frameworks are in place. This review surveys the current landscape and outlines practical paths forward to achieve this goal.
Insights
The Worldwide Innovative Network (WIN) Consortium for Precision Medicine is building a global cancer database. This database will integrate diverse patient data to advance precision oncology and improve cancer treatment outcomes worldwide.
Area of Science:
- Oncology
- Genomics
- Bioinformatics
Background:
- Precision medicine transforms cancer care through molecular profiling and targeted therapies.
- Tumors are increasingly classified into rare subgroups based on multidimensional profiling.
- Existing clinicogenomic databases often lack comprehensive global diversity.
Purpose of the Study:
- To review emerging cancer treatment data and molecular profiling technologies.
- To define requirements for a global cancer database supporting precision oncology.
- To address the need for inclusive datasets reflecting global demographic and lifestyle diversity.
Main Methods:
- Narrative review of cancer treatment data, molecular profiling, and clinicogenomic databases.
- Analysis of tumor characterization, subgroup definition, and data capture of demographic/lifestyle factors.
- Exploration of pathways for creating a global cancer database with clinical and molecular detail.
Main Results:
- Molecular profiling reveals tumors as composites of rare subgroups with distinct biology.
- Vast databases are needed to capture racial, ethnic, genomic, and lifestyle diversity.
- Global diversity in genomic signals and treatment responses is evident across populations.
Conclusions:
- A global cancer database is essential for advancing precision oncology.
- Such a database must incorporate diverse genomic, clinical, lifestyle, and environmental data.
- WIN is developing frameworks for a large-scale, AI-ready global cancer database with robust governance.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
